Spots Global Cancer Trial Database for A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy
Official Title:
Study ID: NCT00257478
Interventions
Study Description
Brief Summary: A study for the treatment of hormone refractory prostate cancer (HRPC) in patients previously treated with chemotherapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
, Tuscon, Arizona, United States
, Los Angeles, California, United States
, Coeur d'Alene, Idaho, United States
, Bronx, New York, United States
, New York, New York, United States
, Philadelphia, Pennsylvania, United States
, San Antonio, Texas, United States
, Amsterdam, , Netherlands
, Sutton, Surry, United Kingdom
Contact Details
Name: D. Buell, MD
Affiliation: Astellas Pharma US, Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
